In the day to day life, healthcare professionals and researchers worldwide work round the clock to fight the crisis. Clinical trials are being conducted to study the safety and efficacy of several drugs, used for the treatment of diabetes, heart failure, reduced ejection fraction, neuropathy, etc. Hypertrophic Cardiomyopathy (HCM) affects the heart muscles, causing hypertrophy, left ventricular stiffness, mitral valve regurgitation, and cellular changes. The treatment strategy aims to prevent associated symptoms and reduce risks such as heart failure and sudden cardiac death.
However, the treatment and management vary from patient to patient based on the severity of the clinical condition. The selection of an appropriate management strategy is needed to overcome the complications. In this regard, Docplexus , in association with the Care Institute of Medical Sciences (CIMS) and Joint…
